Global Market Access and Pricing

In a highly dynamic and evolving global healthcare environment, demonstrating the value of your product is key to ensuring patient access and commercial success. We support Pharmaceutical and Medtech companies with their global market access and pricing strategy.

We address key business questions, from commercial potential, to competitor analysis, to the best way to communicate your product’s value story.

We are leaders in:

  • Global pricing and market access strategy
  • Market opportunity assessment and landscape analysis
  • Stakeholder mapping
  • Reimbursement and HTA decision trend analysis
  • Value communication strategy
  • Global value proposition development and testing
  • Global value dossiers
  • Clinical development strategy and planning
  • Commercial analysis and strategy

Why choose Mtech Access?

  • We have experience and capabilities spanning global markets including:
    • Europe (EU5, Nordic countries, Portugal, Poland, Switzerland, Romania)
    • LATAM (Brazil, Mexico, Chile, Colombia, Argentina)
    • US and Canada
    • Australasia
    • Asia (Korea, Japan, China, Taiwan)
  • Our global market access and pricing specialists have 60+ years’ collective experience
  • We work with an extensive network of stakeholders to deliver primary research
  • We also have access to a broad network of in-country market access experts to support market-specific needs
  • We’ll be by your side from phase 1 through to post-launch, guiding you through each stage of your global market access journey
  • We have developed 55+ global value propositions and global value dossiers for 24+ different clients across more than 24 therapeutic areas
  • We have an interactive global value dossier platform to house your GVDs, enable efficient updates and ensure your affiliates always have the latest evidence to hand

To discuss your strategy with our experts, get in touch using the form below.